Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

BACKGROUND: We investigated whether combinations of serum cytokines, used with logistic disease predictor models, could facilitate the detection of pancreatic ductal adenocarcinoma (PDAC). METHODS: The serum levels of 27 cytokines were measured in 241 subjects, 127 with PDAC, 49 with chronic pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, Victoria E, Lane, Brian, Jenkinson, Claire, Cox, Trevor, Greenhalf, William, Halloran, Christopher M, Tang, Joseph, Sutton, Robert, Neoptolemos, John P, Costello, Eithne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032456/
https://www.ncbi.nlm.nih.gov/pubmed/24884871
http://dx.doi.org/10.1186/1476-4598-13-114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032456/
https://www.ncbi.nlm.nih.gov/pubmed/24884871
http://dx.doi.org/10.1186/1476-4598-13-114

Ejemplares similares